Juno Therapeutics, Inc. 3 SEC Filings

Filed On	Filing
06 Mar 2018	Form 3: Celgene Corp /DE/, 10% owner and 2 others Holds 11,109,160 shares of Common Stock
28 Nov 2017	Form 3: Lee Ann L., EVP, Technical Operations No securities owned
23 May 2017	Form 3: Flatley Jay T, Director Holds 1,500 shares of Common Stock
19 Apr 2017	Form 3: Vessey Rupert, Director No securities owned
17 Apr 2017	Form 3: Agarwal Sunil, President of R & D No securities owned
02 Nov 2015	Form 3: Azelby Robert, See Remarks No securities owned
13 Aug 2015	Form 3: Daniel Thomas O, Director No securities owned
01 Jun 2015	Form 3: Levitsky Hyam, See Remarks No securities owned
18 Dec 2014	Form 3: Klausner Richard, Director Holds 982,499 shares of Common Stock
18 Dec 2014	Form 3: Barron Hal, Director
18 Dec 2014	Form 3: Tessier-Lavigne Marc, Director Holds 75,000 shares of Common Stock
18 Dec 2014	Form 3: Pien Howard H, Director Holds 75,000 shares of Common Stock
18 Dec 2014	Form 3: Bishop Hans Edgar, Director Holds 2,724,859 shares of Common Stock
18 Dec 2014	Form 3: Wilderotter Mary Agnes, Director
18 Dec 2014	Form 3: Nelsen Robert, Director Holds 1,097,015 shares of Common Stock
18 Dec 2014	Form 3: Arch Venture Fund Vii Lp, 10% owner and 4 others Holds 1,097,015 shares of Common Stock
18 Dec 2014	Form 3: Frohlich Mark W, See Remarks Holds 937,500 shares of Common Stock
18 Dec 2014	Form 3: Evnin Anthony B, Director Holds 75,000 shares of Common Stock
18 Dec 2014	Form 3: Bratton Douglas K, 10% owner and 4 others Holds 363,398 shares of Common Stock
18 Dec 2014	Form 3: Harr Steve, See Remarks Holds 800,000 shares of Common Stock

Comments